Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Web Exclusives
FDA Approvals
,
Select Drug Profiles
Opdivo plus Yervoy First Immunotherapy Approved for Unresectable Malignant Pleural Mesothelioma
Read More
FDA Approvals
,
Select Drug Profiles
FDA Approves First Prostate-Specific Membrane Antigen–Targeted PET Imaging Drug for Prostate Cancer
Read More
FDA Approvals
,
Leukemia
,
Select Drug Profiles
Oral Onureg First Drug Approved for Adults with AML in Remission
Read More
FDA Approvals
,
Select Drug Profiles
Danyelza Receives FDA Approval for High-Risk Neuroblastoma in the Bone and Bone Marrow
Read More
FDA Approvals
,
Select Drug Profiles
Gavreto, a New RET Inhibitor, Now Approved for Thyroid Cancer with RET Fusions
Read More
Editorial
The Dirty Dozen Redux
David B. Nash, MD, MBA
Read More
ESMO 2020 Highlights
Olaparib a New Option for Men with Metastatic Prostate Cancer and BRCA Mutation
Phoebe Starr
Read More
ESMO 2020 Highlights
Nivolumab New Standard of Care in Gastroesophageal Cancers as First-Line or Adjuvant Therapy
Phoebe Starr
Read More
Editorial
UnHealthcare
David B. Nash, MD, MBA
Read More
COVID-19
COVID-Related Death Rate Tripled in Patients with Cancer versus the General Population
Phoebe Starr
Read More
10
11
12
13
14
15
16
Page 13 of 37
Results 121 - 130 of 367